Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Correvio Pharma Corp. (CORV)

0.36   -0.11 (-23.4%) 02-25 16:00
Open: 0.5265 Pre. Close: 0.47
High: 0.6486 Low: 0.34
Volume: 52,726,708 Market Cap: 17M
Correvio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide. Its portfolio of marketed brands comprise Aggrastat (tirofiban hydrochloride) for patients with acute coronary syndrome; and Brinavess (vernakalant IV) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm. The company also offers ESMOCARD and ESMOCARD LYO, a short acting beta blocker for the treatment of supraventricular tachycardia and control of the ventricular rate in patients with atrial fibrillation; Trevyent, a development stage drug/device combination product for pulmonary arterial hypertension; Xydalba, a treatment for acute bacterial skin and skin structure infections; and Zevtera/Mabelio, a cephalosporin antibiotic for intravenous administration with rapid bactericidal activity. Correvio Pharma Corp. was incorporated in 2018 and is headquartered in Vancouver, Canada.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.65 - 0.654 0.654 - 0.656
Low: 0.336 - 0.338 0.338 - 0.339
Close: 0.357 - 0.36 0.36 - 0.363

Technical analysis

as of: 2020-02-25 4:28:24 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.56     One year: 0.76
Support: Support1: 0.21    Support2: 0.17
Resistance: Resistance1: 0.48    Resistance2: 0.65
Pivot: 0.32
Moving Average: MA(5): 0.34     MA(20): 0.32
MA(100): 1.17     MA(250): 1.94
MACD: MACD(12,26): -0.04     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 59.87     %D(3): 60.47
RSI: RSI(14): 47.79
52-week: High: 4.44  Low: 0.21  Change(%): -89.3
Average Vol(K): 3-Month: 541104  10-Days: 1113236

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CORV has closed below upper band by 29.4%. Bollinger Bands are 74.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to CORV's normal range. The bands have been in this narrow range for 36 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2020-01-31
CORREVIO INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Correvio Pharma Corp. (“Correvio” or the “Company”) (NASDAQ:CORV) of the February 10, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Correvio stock or options between October 23, 2018 and December 5, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/CORV.

2020-01-02
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation
LOS ANGELES--(BUSINESS WIRE)---- $CORV--Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 50.52
Shares Float (M) 49.44
% Held by Insiders 2.31
% Held by Institutions 9.22
Shares Short (K) 1830
Shares Short P. Month (K)

Stock Financials

EPS -0.905
Book Value (p.s.) 0.030
PEG Ratio -0.01
Profit Margin -121.25
Operating Margin -84.44
Return on Assets (ttm) -26.3
Return on Equity (ttm) -628.2
Qtrly Rev. Growth -4.8
Gross Profit (p.s.) 0.403
Sales Per Share
EBITDA (p.s.) -0.428
Qtrly Earnings Growth
Operating Cash Flow (M) -25.56
Levered Free Cash Flow (M) -10.02

Stock Valuations

P/E -0.40
P/E Growth Ratio -0.23
P/BV 12.00
P/S 0.48
P/CF -0.71

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2013-04-11
Last Split Ratio 0.2
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.